Skip to main content
. 2011 Feb;52(1):48–54. doi: 10.3325/cmj.2011.52.48

Table 2.

Comparison of demographic and epidemiologic data on patients who did and did not receive antipyretic drugs for the upper respiratory tract infection (URTI) before visiting a physician


No. (%) of patients

Characteristic treated with antipyretics (n = 51) not treated with antipyretics (n = 120) P
Age, years, median (range)
6.0 (3.0-9.0)
5.0 (3.5-7.0)
0.360*
Age group



2-3 y
13 (25.5)
27 (22.5)
0.457
3.1-6.9 y
19 (37.3)
57 (47.5)

≥7 y
19 (37.3)
36 (30.0)

Sex:



male
27 (52.9)
70 (58.3)
0.613
female
24 (47.1)
50 (41.7)

Chronic diseases
2 (3.9)
6 (5.0)
1.000
Allergies
7 (13.7)
5 (4.2)
0.044
Attending day-care center
25 (49.0)
84 (70.0)
0.014
Attending school
19 (37.3)
35 (29.2)§
0.369
Having siblings
30 (58.8)§
79 (65.8)
0.391
Having sister(s)
16 (31.4)
60 (50.0)
0.029
Having brother(s)
18 (35.3)
41 (34.2)
0.999
Recent URTI in family
17 (33.3)§
9 (7.5)
<0.001
Frequent URTI
17 (33.3)
67 (55.8)
0.008
Sudden onset of URTI episode
27 (52.9)
60 (50.0)
0.741
Duration of symptoms, days, median (range) 3.0 (2.0-4.0) 3.0 (3.0-3.0) 0.275*

*Wilcoxon test.

†χ2 test.

‡Fisher exact test.

§Data missing for 1 patient.

║Data missing for 4 patients.